The greater a company's earnings, the better its position will be to pay dividends. However, Pfizer's adjusted earnings per ...

Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.

Tuesday's quarterly earnings release underscored the necessity for new revenue drivers. Although Pfizer exceeded analyst expectations with earnings of $0.87 per share against projections of $0.79, ...

Pfizer beat earnings expectations decisively this morning, with shares of PFE gapping up more than 12% in pre-market trading.

High-yield dividend stocks offer two key benefits. They provide regular cash flow through dividend payments and, when dividends are consistently reinvested, have often outperformed the S&P 500 over ...

This out-of-favor drug maker is taking the steps needed to ensure it not only survives but thrives over the long term.

Much of Pfizer’s revenue is driven by therapies with only modest competition. This stock is also developing a very impressive dividend-growth track record. Pfizer remains one of the market’s most ...

A dividend yield that surpasses 7.5% from a pharmaceutical sector giant like Pfizer Inc. (NYSE: PFE) certainly catches the eye of income-seeking investors. Such a substantial return often signals a ...

Pfizer Inc. (NYSE:PFE) is included among the Best Retirement Stocks for a Dividend Stock Portfolio. Pfizer Inc. (NYSE:PFE) is an American multinational pharmaceutical and biotech company. The last ...

Pfizer Inc. (NYSE:PFE) will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 5. Analysts expect the pharmaceutical company to report quarterly earnings of 57 ...